Solarplast (R) Supplementation Effects Following High-intensity Resistance Exercise

Launched by KENT STATE UNIVERSITY · May 22, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a supplement called Solarplast (R) on recovery after intense weightlifting exercises in active adults. The main questions researchers want to answer are whether Solarplast (R) can reduce muscle damage and inflammation that often occur after heavy workouts and whether it helps maintain exercise performance during recovery. To find this out, participants will either take Solarplast (R) or a placebo (which looks the same but has no active ingredients) for four weeks.

To be eligible for this study, participants should be active adults who work out with weights at least twice a week and participate in overall structured exercise for at least three hours weekly. They should also be healthy without any serious medical conditions and willing to follow their usual diet without taking other supplements during the study. Participants will need to visit the laboratory weekly to receive their supplement and will undergo heavy resistance training sessions followed by tests to assess their recovery. This trial is currently recruiting participants and welcomes individuals of all genders aged between 18 and 34.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Recreationally-active (participated in at least 2 weight training workouts per week over the previous year) and participates in at least 3h of total structured exercise/week as determined by the health and activity questionnaire.
• • Subject is judged by the Investigator to be healthy and free of any physical limitations (determined by health and activity questionnaire)
• • Subject has a body mass index of 18.0-34.9 kg/m2, inclusive
• • Subject is willing to maintain habitual diet throughout the study period
• • Subject is willing to abstain from dietary supplementation throughout the duration of the study.
• • Subject understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators
• Exclusion Criteria:
• • Subject is currently or will be enrolled in another clinical trial.
• • Subject is a habitual consumer of tea/antioxidants defined as \> 8 oz/day of either green or black tea within the 14 days prior to the screening visit.
• • Subject has a history or presence of a clinically relevant cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder.
• • Subject has a history or presence of cancer in the prior 2 years, except for non-melanoma skin cancer.
• • Subject is unable to perform physical exercise (determined by health and activity questionnaire)
• • Subject is engaged in an extreme diet including but not limited to, Atkins, South Beach, Intermittent Fasting, etc.
• • Subject is allergic to the study product or placebo
• • Subject is taking any other nutritional supplement or performance enhancing drug (determined from health and activity questionnaire)
• • Subject has any chronic illness that causes continuous medical care
• • Taking any type of prescription or over-the-counter medication including but not limited to corticosteroids, non-steroidal anti-inflammatory drugs, and antibiotics within the 14 days prior to the screening visit.